References and Notes
-
1a
Pearson WH.
Lee IY.
Mi Y.
Stoy P.
J. Org. Chem.
2004,
69:
9109
-
1b
Arya P.
Couve-Bonnaire S.
Durieux P.
Laforce D.
Kumar R.
Leek DM.
J. Comb. Chem.
2004,
6:
735
-
1c
Hansen LK.
Stormer FC.
Petersen D.
Aasen AJ.
Acta Crystallogr., Sect. E: Struct. Rep. Online
2001,
57:
909
-
2a
Kaul R.
Surprenant S.
Lubell WD.
J. Org. Chem.
2005,
70:
3838
-
2b Correction: Kaul R.
Surprenant S.
Lubell WD.
J. Org. Chem.
2005,
70:
4901
-
2c
Derrer S.
Davies JE.
Holmes AB.
J. Chem. Soc., Perkin Trans. 1
2000,
2943
-
2d
Derrer S.
Davies JE.
Holmes AB.
J. Chem. Soc., Perkin Trans. 1
2000,
2957
-
2e
Derrer S.
Feeder N.
Teat SJ.
Davies JE.
Holmes AB.
Tetrahedron Lett.
1998,
39:
9309
- 3
Alcaide B.
Rodríguez-Ranera C.
Rodríguez-Vicente A.
Tetrahedron Lett.
2001,
42:
3081
-
4a
Hernández R.
Melián D.
Prangé T.
Suárez E.
Heterocycles
1995,
41:
439
-
4b
Dorta RL.
Francisco CG.
Suárez E.
Tetrahedron Lett.
1994,
35:
1083
-
4c
Hernández R.
Marrero JJ.
Melián D.
Suárez E.
Tetrahedron Lett.
1988,
29:
6661
-
5a
Hansford KA.
Guarin SAP.
Skene WG.
Lubell WD.
J. Org. Chem.
2005,
70:
7996
-
5b
Yuguchi M.
Tokuda M.
Orito K.
J. Org. Chem.
2004,
69:
908
-
5c
Demirayak S.
Karaburun AC.
Beis R.
Eur. J. Med. Chem.
2004,
39:
1089
-
5d
Raghavan S.
Anuradha K.
Synlett
2003,
711
-
5e
Just PE.
Chane-Ching KI.
Lacaze PC.
Tetrahedron
2002,
58:
3467
-
5f Review: Ferreira VF.
de Souza MCBV.
Cunha AC.
Pereira LOR.
Ferreira MLG.
Org. Prep. Proced. Int.
2001,
33:
413
-
6a
Rössle M.
Werner T.
Frey W.
Christoffers J.
Eur. J. Org. Chem.
2005,
5031
-
6b
Rössle M.
Werner T.
Baro A.
Frey W.
Christoffers J.
Angew. Chem. Int. Ed.
2004,
43:
6547 ; Angew. Chem. 2004, 116, 6709
-
6c
Christoffers J.
Werner T.
Frey W.
Baro A.
Eur. J. Org. Chem.
2003,
4879
-
7a
Banik BK.
Banik I.
Renteria M.
Dasgupta SK.
Tetrahedron Lett.
2005,
46:
2643
-
7b
Yadav JS.
Reddy BVS.
Eeshwaraiah B.
Gupta MK.
Tetrahedron Lett.
2004,
45:
5873
- 12
Yamasaki T.
Yoshihara Y.
Okamoto Y.
Okawara T.
Furukawa M.
Heterocycles
1996,
43:
1613
8
Ethyl 1-Butyl-8-oxo-2-phenyl-1,4,5,6,7,8-hexahydro-azocine-4-carboxylate (
2c): A suspension of ester 1 (100 mg, 365 µmol), n-BuNH2 (133 mg, 1.83 mmol, 5 equiv), and Bi(NO3)3·5H2O (9 mg, 18 µmol, 0.05 equiv) in THF (1.0 mL) was stirred in a closed reaction vial for 2 d at 70 °C. After cooling to ambient temperature, the reaction mixture was chromatographed (basic alumina; hexanes-EtOAc, 2:1) to give lactam 2c (74 mg, 223 µmol, 61%) as a yellowish oil; R
f
(silica) 0.32. IR (ATR): 2956 (m), 2931 (s), 2862 (m), 1733 (vs), 1654 (vs), 1446 (s), 1399 (s), 1179 (s) cm-1. 1H NMR (CDCl3, 500 MHz): δ = 0.83 (t, J = 7.4 Hz, 3 H), 1.19-1.26 (m, 2 H), 1.30 (t, J = 7.1 Hz, 3 H), 1.33-1.37 (m, 1 H), 1.41-1.55 (m, 1 H), 1.75-1.85 (m, 1 H), 1.99-2.04 (m, 1 H), 2.13-2.18 (m, 2 H), 2.44 (dt, J = 1.4 Hz, J = 12.3 Hz, 1 H), 2.51 (ddd, J = 1.4 Hz, J = 8.0 Hz, J = 11.9 Hz, 1 H), 2.65 (ddd, J = 5.0 Hz, J = 10.0 Hz, J = 13.6 Hz, 1 H), 3.04 (ddd, J = 0.9 Hz, J = 10.2 Hz, J = 10.6 Hz, 1 H), 4.09 (ddd, J = 6.0 Hz, J = 9.9 Hz, J = 13.4 Hz, 1 H), 4.21 (q, J = 7.1 Hz, 2 H), 6.02 (d, J = 9.9 Hz, 1 H), 7.36-7.38 (m, 5 H) ppm. 13C NMR (CDCl3, 125 MHz): δ = 13.79 (CH3), 14.20 (CH3), 20.31 (CH2), 24.13 (CH2), 29.39 (CH2), 29.60 (CH2), 33.59 (CH2), 43.79 (CH), 44.65 (CH2), 61.03 (CH2), 124.34 (CH), 126.28 (2 × CH), 128.84 (2 × CH), 128.94 (CH), 135.73 (C), 140.44 (C), 173.85 (C), 173.87 (C) ppm. MS (70 eV, EI): m/z (%) = 329 (100) [M+]. Anal. Calcd for C20H27NO3: C, 72.92; H, 8.26; N, 4.25. Found: C, 73.07; H, 8.35; N, 4.31.
9
Ethyl 4,5,6,6a-Tetrahydro-6a-hydroxy-2-phenyl-3
H
-cyclopenta[
b
]pyrrole-3a-carboxylate (
3): A mixture of ester 1 (56 mg, 0.20 mmol), molecular sieves (4 Å, ca. 90 mg) and liquid NH3 (ca. 4 mL) was stirred for 7 h at -75 °C. After evaporation of the solvent upon warming to ambient temperature the residue was suspended in CHCl3 (ca. 2 mL), filtered, the solvent again evaporated, and the residue chromatographed (silica; hexanes-EtOAc-Et3N, 8.3:1.7:1) to give 3 (35 mg, 0.13 mmol, 63%) as light brown crystals. Mp 142 °C; R
f
(silica; hexanes-EtOAc, 2:1) 0.18. IR (ATR): 3066 (br, m), 2962 (m), 2929 (m), 2799 (m), 1724 (vs), 1627 (s), 1577 (m), 1450 (m), 1362 (m), 1345 (m), 1322 (m), 1298 (s), 1284 (s), 1235 (m), 1184 (s), 1146 (s), 1125 (s), 1087 (s), 1023 (m), 942 (w) cm-1. 1H NMR (500 MHz, CDCl3): δ = 1.30 (t, J = 7.1 Hz, 3 H), 1.32-1.42 (m, 1 H), 1.73 (ddt, J = 13.1 Hz, J = 6.2 Hz, J = 2.0 Hz, 1 H), 1.77-1.84 (m, 1 H), 2.05 (dt, J = 12.5 Hz, J = 6.6 Hz, 1 H), 2.26 (ddt, J = 12.9 Hz, J = 6.0 Hz, J = 2.0 Hz, 1 H), 2.66 (dt, J = 12.3 Hz, J = 6.6 Hz, 1 H), 2.89 (d, J = 18.0 Hz, 1 H, CHH), 4.02 (d, J = 18.0 Hz, 1 H, CHH), 4.07 (s, br, 1 H, OH), 4.19-4.26 (m, 2 H), 7.40-7.44 (m, 2 H), 7.46-7.50 (m, 1 H), 7.85-7.89 (m, 2 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 14.26 (CH3), 22.85 (CH2), 37.47 (CH2), 39.96 (CH2), 48.13 (CH2), 58.92 (C), 61.29 (CH2), 116.03 (C), 128.24 (2 × CH), 128.52 (2 × CH), 131.37 (CH), 133.21 (C), 171.99 (C), 174.25 (C) ppm. MS (EI, 70 eV): m/z (%) = 273 (78) [M+], 244 (30) [M+ - Et], 231 (36), 200 (100) [M+ - CO2Et]. Anal. Calcd C16H19NO3: C, 70.36; H, 7.01; N, 5.13. Found: C, 70.05; H, 7.07; N, 4.99.
10
Ethyl 1-(Benzoylmethyl)-2-phenylhydrazonocyclo-pentane-1-carboxylate (
5): A solution of ester 1 (400 mg, 1.46 mmol) in EtOH (2.0 mL) was added to a mixture of phenylhydrazine (176 mg, 1.63 mmol, 1.1 equiv), AcOH (0.68 mL), and EtOH (4.0 mL). After stirring for 30 min at 23 °C the mixture was poured onto ice and H2O (ca. 25 g). After filtration the residue was dried in vacuo to give a yellow solid (500 mg, 1.37 mmol, 94%). Mp 106 °C. IR (ATR): 3320 (m), 2968 (m), 1700(vs), 1685 (vs), 598 (vs), 1494 (m), 1229 (vs), 1180 (s), 1128 (s) cm-1. 1H NMR (CDCl3, 500 MHz): δ = 1.20 (t, J = 7.1 Hz, 3 H), 1.83 (ddd, J = 7.7 Hz, J = 9.8 Hz, J = 13.1 Hz, 1 H), 1.94-2.00 (m, 1 H), 2.16-2.25 (m, 1 H), 2.35-2.42 (m, 1 H), 2.48 (ddd, J = 3.9 Hz, J = 9.4 Hz, J = 17.2 Hz, 1 H), 2.77 (ddd, J = 3.4 Hz, J = 7.3 Hz, J = 13.0 Hz, 1 H), 3.23 (d, J = 18.1 Hz, 1 H), 4.11 (d, J = 18.1 Hz, 1 H), 4.16 (q, J = 7.0 Hz, 2 H), 6.80-6.83 (m, 1 H), 6.98-7.01 (m, 2 H), 7.17-7.21 (m, 2 H), 7.36 (s, 1 H), 7.44-7.48 (m, 2 H), 7.54-7.57 (m, 1 H), 7.98-8.00 (m, 2 H) ppm. 13C NMR (CDCl3, 125 MHz): δ = 14.08 (CH3), 22.46 (CH2), 26.25 (CH2), 35.60 (CH2), 45.69 (CH2), 54.44 (C), 61.00 (CH2), 112.90 (2 × CH), 119.92 (CH), 128.06 (2 × CH), 128.54 (2 × CH), 129.11 (2 × CH), 133.03 (CH), 137.09 (C), 145.36 (C), 153.46 (C), 173.27 (C), 197.97 (C) ppm. MS (EI, 70 eV): m/z calcd for C22H24N2O3 [M+], 364.1787; found, 364.1788.
11
Ethyl 2,3-Diphenyl-2,5,6,7-tetrahydrocyclo-penta[
c
]pyridazine-4a-carboxylate (
6): TFA (1 drop, ca. 10 mg) was added to a suspension of hydrazone 5 (60 mg, 0.16 mmol) and MgSO4 (150 mg) in CH2Cl2 (2.0 mL). After stirring the mixture for 4 h at 23 °C all volatile materials were removed in vacuo and the residue chromatographed (basic alumina; hexanes-EtOAc, 10:1) to give pyridazine 6 (30 mg, 87 µmol, 54%) as a yellow oil. R
f
(silica; hexanes-EtOAc, 2:1) 0.64. IR (ATR): 2976 (m), 1719 (vs), 1597 (s), 1495 (m), 1355 (m), 1221 (s), 1026 (m) cm-1. 1H NMR (CDCl3, 500 MHz): δ = 1.14 (t, J = 7.1 Hz, 3 H), 1.78-1.86 (m, 1 H), 1.93-2.06 (m, 2 H), 2.64-2.71 (m, 2 H), 2.89 (ddd, J = 6.5 Hz, J = 9.0 Hz, J = 16.8 Hz, 1 H), 4.05-4.12 (m, 2 H), 4.79 (s, 1 H), 6.85-6.89 (m, 1 H), 7.03-7.05 (m, 2 H), 7.07-7.11 (m, 2 H), 7.18-7.23 (m, 5 H) ppm. 13C NMR (CDCl3, 125 MHz): δ = 14.05 (CH3), 22.50 (CH2), 30.17 (CH2), 37.06 (CH2), 51.05 (C), 61.17 (CH2), 101.22 (CH), 121.16 (2 × CH), 122.55 (CH), 127.99 (3 × CH), 128.20 (2 × CH), 128.69 (2 × CH), 135.51 (C), 140.38 (C), 143.52 (C), 153.38 (C), 172.89 (C) ppm. MS (CI, CH4): m/z calcd for C22H23N2O2 [M + H+], 347.1759; found, 347.1766.